| Price | 1.975p on 18-09-2026 at 18:35:06 |
|---|---|
| Change | 0.08p 4.1% |
| Buy | 2.05p |
| Sell | 1.90p |
| Last Trade: | Buy 8,339.00 at 2.03p |
| Day's Volume: | 4,972,601 |
| Last Close: | 2.03p |
| Open: | 1.90p |
| ISIN: | GB00BP2C3V08 |
| Day's Range | 1.90p - 2.03p |
| 52wk Range: | 0.925p - 3.12p |
| Market Capitalisation: | £11.50m |
| VWAP: | 1.965966p |
| Shares in Issue: | 566.41m |
Sector: Medicine and Biotech
Genflow Biosci (GENF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 8,339 | 2.03p | Suspected BUY Trade |
16:35:04 - 18-Sep-26 |
| Sell* | 59,780 | 1.9525p | Ordinary |
16:29:23 - 18-Sep-26 |
| Sell* | 55,000 | 1.9525p | Ordinary |
16:25:36 - 18-Sep-26 |
| Sell* | 48,133 | 1.9525p | Ordinary |
16:21:42 - 18-Sep-26 |
| Sell* | 270,000 | 1.97p | Ordinary |
16:19:26 - 18-Sep-26 |
| Sell* | 10 | 1.97p | Ordinary |
15:46:38 - 18-Sep-26 |
| Sell* | 10,000 | 1.9525p | Ordinary |
15:40:18 - 18-Sep-26 |
| Sell* | 375,000 | 1.9525p | Ordinary |
15:35:05 - 18-Sep-26 |
| Sell* | 37,881 | 1.97p | Ordinary |
15:23:09 - 18-Sep-26 |
| Sell* | 250,000 | 1.95p | Ordinary |
14:29:18 - 18-Sep-26 |
Genflow Biosci (GENF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Sep 2026 7:00 am | RNS | Primary Endpoint in SLAB Clinical Trial Met |
| 7th Sep 2026 7:00 am | RNS-R | Appointment of Investor Relations Adviser |
| 3rd Aug 2026 7:00 am | RNS | Patent Update |
| 13th Jul 2026 7:00 am | RNS-R | Mid-Year Operational and Corporate Summary |
| 29th Jun 2026 12:02 pm | RNS | Result of AGM |
| 22nd Jun 2026 7:00 am | RNS-R | Participation at BIO International Convention 2026 |
| 17th Jun 2026 7:00 am | RNS | Company to present at Animal Longevity Summit 2026 |
| 4th Jun 2026 7:00 am | RNS | Notice of AGM |
| 8th May 2026 10:07 am | RNS | Exercise of Warrants and Issue of Equity |
| 30th Apr 2026 1:12 pm | RNS | Final Results |
